REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/09/2025
Voltar para busca
Dado oficial do USPTO
MOBIDIAG
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
09/09/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 10
Data de depósito
22/01/2018
Data de registro
08/09/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/09/2020
Última transação
09/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
5
Tipo de titular
99
Localização do titular
ESPOO, FI
Examinador
PEISECKI, MARK
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized letters "MOBIDIAG" with the letters "MOBI" in light blue and "DIAG" in grey.
Titulares e representantes
Titulares
Mobidiag Oy
Representantes
Charles F. Reidelbach, Jr., Esq. HIGGS FLETCHER & MACK LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagents for scientific and research use; Reagents, other than for medical use, for sale in kit form and comprising of reagents for detecting nucleic acids or other biological markers; Reagents for in-vitro use, other than for medical purposes; Diagnostic preparations and reagents for scientific and research use, for in- vitro use, and other than medical use; chemical tests for scientific and research use for detecting nucleic acids or other biological markers; chemical tests, other than for medical use for sale in kit form for detecting nucleic acids or other biological markers; chemical tests for in-vitro use, other than for medical use, for detecting nucleic acids or other biological markers
Classe 5
Pharmaceutical and veterinary preparations for detecting nucleic acids or other biological markers from animals or their microbes; sanitary preparations for medical purposes; Medical diagnostic reagents and assays that test for the presence of pathogens and infection; medical diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of pathogens and infection; medical diagnostic reagents and assays that test body fluids for microorganisms; medical diagnostic kits comprised of medical diagnostic reagents and assays that test body fluids for microorganisms; medical diagnostic reagents for the extraction, amplification, and purification of nucleic acids; clinical medical reagents and assays for the extraction amplification, and purification of nucleic acids
Classe 9
Computer hardware and software for scientific, industrial and medical analysis and research purposes, namely, computer hardware and recorded software for use in in-vitro diagnostics and for detecting nucleic acids or other biological markers, in particular for the diagnosis of medical conditions in humans and animals; laboratory robots
Classe 10
Surgical, medical, dental and veterinary equipment and instruments for clinical diagnosis purposes, namely, laboratory equipment for use in in-vitro diagnostics or for detecting nucleic acids or other biological markers, in particular for detecting infectious diseases, for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/10/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
13/10/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/10/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/10/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/06/2020
PUBO
PUBLISHED FOR OPPOSITION
23/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/05/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
15/05/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
15/05/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
15/05/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/11/2019
GNRT
NON-FINAL ACTION E-MAILED
08/11/2019
CNRT
NON-FINAL ACTION WRITTEN
08/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/08/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
19/02/2019
GPRA
PRIORITY ACTION E-MAILED
19/02/2019
CPRA
PRIORITY ACTION WRITTEN
19/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/11/2018
ALIE
ASSIGNED TO LIE
19/11/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/05/2018
GNRT
NON-FINAL ACTION E-MAILED
08/05/2018
CNRT
NON-FINAL ACTION WRITTEN
08/05/2018
DOCK
ASSIGNED TO EXAMINER
02/05/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/02/2018
NWAP
NEW APPLICATION ENTERED
25/01/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MOBIDIAG ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.